Advertisement

Cell and Tissue Research

, Volume 349, Issue 2, pp 505–515 | Cite as

Defining essential stem cell characteristics in adipose-derived stromal cells extracted from distinct anatomical sites

  • Patrick C. Sachs
  • Michael P. Francis
  • Min Zhao
  • Jenni Brumelle
  • Raj R. Rao
  • Lynne W. ElmoreEmail author
  • Shawn E. HoltEmail author
Regular Article

Abstract

The discovery of adipose-derived stromal cells (ASCs) has created many opportunities for the development of patient-specific cell-based replacement therapies. We have isolated multiple cell strains of ASCs from various anatomical sites (abdomen, arms/legs, breast, buttocks), indicating widespread distribution of ASCs throughout the body. Unfortunately, there exists a general lack of agreement in the literature as to their “stem cell” characteristics. We find that telomerase activity and expression of its catalytic subunit in ASCs are both below the levels of detection, independent of age and culturing conditions. ASCs also undergo telomere attrition and eventually senesce, while maintaining a stable karyotype without the development of spontaneous tumor-associated abnormalities. Using a set of cell surface markers that have been promoted to identify ASCs, we find that they failed to distinguish ASCs from normal fibroblasts, as both are positive for CD29, CD73 and CD105 and negative for CD14, CD31 and CD45. All of the ASC isolates are multipotent, capable of differentiating into osteocytes, chondrocytes and adipocytes, while fibroblasts show no differentiation potential. Our ASC strains also show elevated expression of genes associated with pluripotent cells, Oct-4, SOX2 and NANOG, when compared to fibroblasts and bone marrow-derived mesenchymal stem cells (BM-MSCs), although the levels were lower than induced pluripotent stem cells (iPS). Together, our data suggest that, while the cell surface profile of ASCs does not distinguish them from normal fibroblasts, their differentiation capacity and the expression of genes closely linked to pluripotency clearly define ASCs as multipotent stem cells, regardless of tissue isolation location.

Keywords

ASC iPS Pluripotent Stem cell Telomere Telomerase 

Notes

Acknowledgements

Special thanks to Dr. Stephen Chen and the Department of Surgery for assisting with the procurement of lipoaspirate and abdominoplasty specimens. This study was supported in part by the Department of Pathology (S.E.H. and L.W.E.), the Department of Human and Molecular Genetics (S.E.H.), K01CA105050 (L.W.E.) from the National Cancer Institute, W81XWH-09-1-0500 (L.W.E.) from the Department of Defense Breast Cancer Research Program and the Jeffress Memorial Trust (L.W.E.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. Flow cytometry was supported in part by the Massey Cancer Center core grant, NIH Grant P30 CA16059.

Author disclosure

All authors agree to the format and content of the manuscript and none have any commercial affiliations or associations that would contemplate a conflict of interest for the data presented.

References

  1. Abdallah BM, Haack-Sørensen M, Burns JS, Elsnab B, Jakob F, Hokland P, Kassem M (2005) Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite extensive proliferation. Biochem Biophys Res Comm 326:527–538PubMedCrossRefGoogle Scholar
  2. Astori G, Vignati F, Bardelli S, Tubio M, Gola M, Albertini V, Bambi F, Scali G, Castelli D, Rasini V, Soldati G, Moccetti T (2007) In vitro and multicolor phenotypic characterization of cell subpopulations identified in fresh human adipose tissue stromal vascular fraction and in the derived mesenchymal stem cells. J Transl Med 5:55PubMedCrossRefGoogle Scholar
  3. Barch M (1991) The AGT cytogenetics manual, 3 rdth edn. Lippencott Williams and Wilkins, Philadelphia, pp 263–265Google Scholar
  4. Elmore LW, Rehder CW, Di M, McChesney PA, Jackson-Cook CK, Gewirtz DA, Holt SE (2002) Adriamycin-induced replicative senescence in tumor cells requires functional p53 and telomere dysfunction. J Biol Chem 277:35509–35515PubMedCrossRefGoogle Scholar
  5. Francis MP, Sachs PC, Elmore LW, Holt SE (2010) Isolating adipose-derived mesenchymal stem cells from lipoaspirate blood and saline fraction. Organogenesis 6:10–14CrossRefGoogle Scholar
  6. Fu WY, Lu YM, Piao YJ (2001) Differentiation and telomerase activity of human mesenchymal stem cells. Di Yi Jun Yi Da Xue Xue Bao 21:801–805PubMedGoogle Scholar
  7. Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA (2006) Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99:1285–1297PubMedCrossRefGoogle Scholar
  8. Izadpanah R, Kaushal D, Kriedt C, Tsien F, Patel B, Dufour J, Bunnell BA (2008) Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68:4229–4238PubMedCrossRefGoogle Scholar
  9. Kang SK, Putnam L, Dufour J, Ylostalo J, Jung JS, Bunnell BA (2004) Expression of telomerase extends the lifespan and enhances osteogenic differentiation of adipose tissue-derived stromal cells. Stem Cells 22:1356–1372PubMedCrossRefGoogle Scholar
  10. Kassem M, Abdallah BM, Yu Z, Ditzel N, Burns JS (2004) The use of hTERT-immortalized cells in tissue engineering. Cytotechnology 45:39–46PubMedCrossRefGoogle Scholar
  11. Katz AJ, Tholpady A, Tholpady SS, Shang H, Ogle RC (2005) Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells 23:412–423PubMedCrossRefGoogle Scholar
  12. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294–1301PubMedCrossRefGoogle Scholar
  13. Leong DT, Khor WM, Chew FT, Lim TC, Hutmacher DW (2005) Viability and adipogenic potential of human adipose tissue processed cell population obtained from pump-assisted and syringe-assisted liposuction. J Dermat Sci 37:169–76CrossRefGoogle Scholar
  14. Lin K, Matsubara Y, Masuda Y, Togashi K, Ohno T, Tamura T, Toyoshima Y, Sugimachi K, Toyoda M, Marc H, Douglas A (2008a) Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 10:417–426PubMedCrossRefGoogle Scholar
  15. Lin G, Garcia M, Ning H, Banie L, Guo YL, Lue TF, Lin CS (2008b) Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 17:1053–1063PubMedCrossRefGoogle Scholar
  16. Noël D, Caton D, Roche S, Bony C, Lehmann S, Casteilla L, Jorgensen C, Cousin B (2008) Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 314:1575–1584PubMedCrossRefGoogle Scholar
  17. Oedayrajsingh-Varma MJ, van Ham SM, Knippenberg M, Helder MN, Klein-Nulend J, Schouten TE, Ritt MJ, van Milligen FJ (2006) Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy 8:166–177PubMedCrossRefGoogle Scholar
  18. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C (2008) Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 17:761–773PubMedCrossRefGoogle Scholar
  19. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ (2004) Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103:1647–1652PubMedCrossRefGoogle Scholar
  20. Poynter KR, Sachs PC, Breed MS, Bright AT, Nguyen BN, Elmore LW, Holt SE (2009) Genetic inhibition of telomerase: implications for recovery and chemosensitization. Molec Cancer Ther 8:1319–1327CrossRefGoogle Scholar
  21. Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC, Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski C, Mansur F, Christofis A, Amaral VF, Brofman PS, Goldenberg S, Nakao LS, Correa A (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233:901–913CrossRefGoogle Scholar
  22. Rooney D, Czepulkowski B (1992) Human cytogenetics: A practical approach, vol II malignancy and acquired abnormalities, 2nd edn. Oxford University Press, New York, pp 198–200Google Scholar
  23. Sugii S, Kida Y, Kawamura T, Suzuki J, Vassena R, Yin YQ, Lutz MK, Berggren WT, Izpisúa Belmonte JC, Evans RM (2010) Human and mouse adipose-derived cells support feeder-independent induction of pluripotent stem cells. Proc Natl Acad Sci USA 107:3558–3563PubMedCrossRefGoogle Scholar
  24. Torsvik A, Røsland GV, Svendsen A, Molven A, Immervoll H, McCormack E, Lønning PE, Primon M, Sobala E, Tonn JC, Goldbrunner R, Schichor C, Mysliwietz J, Lah TT, Motaln H, Knappskog S, Bjerkvig R (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track. Cancer Res 70:6393–6396PubMedCrossRefGoogle Scholar
  25. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, Krause U, Blake J, Schwager C, Eckstein V, Anso (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33:1402–1416PubMedCrossRefGoogle Scholar
  26. Yoshimura K, Shigeura T, Matsumoto D, Sato T, Takaki Y, Aiba-Kojima E, Sato K, Inoue K, Nagase T, Koshima I, Gonda K (2006) Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Phys 208:64–76CrossRefGoogle Scholar
  27. Zhao YM, Li JY, Lan JP, Lai XY, Luo Y, Sun J, Yu J, Zhu YY, Zeng FF, Zhou Q, Huang H (2008) Cell cycle dependent telomere regulation by telomerase in human bone marrow mesenchymal stem cells. Biochem Biophys Res Comm 369:1114–1119PubMedCrossRefGoogle Scholar
  28. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664–675PubMedCrossRefGoogle Scholar
  29. Zimmermann S, Voss M, Kaiser S, Kapp U, Waller CF, Martens UM (2003) Lack of telomerase activity in human mesenchymal stem cells. Leukemia 17:1146–1149PubMedCrossRefGoogle Scholar
  30. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Patrick C. Sachs
    • 1
  • Michael P. Francis
    • 2
  • Min Zhao
    • 2
  • Jenni Brumelle
    • 2
  • Raj R. Rao
    • 1
    • 3
    • 5
  • Lynne W. Elmore
    • 2
    • 5
    Email author
  • Shawn E. Holt
    • 1
    • 2
    • 4
    • 5
    • 6
    Email author
  1. 1.Department of Human and Molecular Genetics, Medical College of Virginia CampusVirginia Commonwealth UniversityRichmondUSA
  2. 2.Department of Pathology, Medical College of Virginia CampusVirginia Commonwealth UniversityRichmondUSA
  3. 3.Chemical and Life Science EngineeringVirginia Commonwealth UniversityRichmondUSA
  4. 4.Department of Pharmacology and Toxicology, Medical College of Virginia CampusVirginia Commonwealth UniversityRichmondUSA
  5. 5.Massey Cancer Center, Medical College of Virginia CampusVirginia Commonwealth UniversityRichmondUSA
  6. 6.Department of BiologyVirginia State UniversityPetersburgUSA

Personalised recommendations